-
1
المؤلفون: Peter Hersey, Jean-Jacques Grob, Blanca Homet Moreno, Omid Hamid, Erin Jensen, Tara C. Mitchell, Georgina V. Long, Jedd D. Wolchok, Ana Arance, Anthony M. Joshua, Matteo S. Carlino, Caroline Robert, Laurent Mortier, Jacob Schachter, Jeffrey S. Weber, F. Stephen Hodi, Adil Daud, Scott J. Diede, Antoni Ribas
المصدر: European journal of cancer (Oxford, England : 1990). 157
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Post hoc, Clinical Decision-Making, Pembrolizumab, Antibodies, Monoclonal, Humanized, Drug Administration Schedule, Stable Disease, Internal medicine, medicine, Long term outcomes, Humans, In patient, Trial registration, Immune Checkpoint Inhibitors, Melanoma, Complete response, Advanced melanoma, Aged, Neoplasm Staging, business.industry, Patient Selection, Middle Aged, Prognosis, Progression-Free Survival, Survival Rate, Oncology, Disease Progression, Female, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91d36204dbb77dc73c57b42b2ef7e542Test
https://pubmed.ncbi.nlm.nih.gov/34571336Test -
2
المؤلفون: Adil Daud, Jeffrey S. Weber, Georgina V. Long, Matteo S. Carlino, Jacob Schachter, Wen-Jen Hwu, Peter Hersey, Caroline Robert, Antoni Ribas, Le Min, Nageatte Ibrahim, Celine Boutros, Igor Puzanov, Jianxin Lin, Scott J. Diede, F. Stephen Hodi, Reinhard Dummer, Omid Hamid, Richard W. Joseph, Roxana S. Dronca, Jedd D. Wolchok, Tara C. Mitchell, Anthony M. Joshua
المساهمون: Intégrité du génome, ARN et cancer, Institut Curie [Paris]-Université Paris-Saclay-Centre National de la Recherche Scientifique (CNRS), University of Zurich, Robert, Caroline
المصدر: European journal of cancer (Oxford, England : 1990)
European Journal of Cancer
European Journal of Cancer, Elsevier, 2021, 144, pp.182-191. ⟨10.1016/j.ejca.2020.11.010⟩مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, [SDV]Life Sciences [q-bio], Immune-checkpoint inhibitors, Pembrolizumab, Gastroenterology, 0302 clinical medicine, Antineoplastic Agents, Immunological, Immune-related adverse events, Monoclonal, 80 and over, 1306 Cancer Research, Melanoma, Humanized, Cancer, Aged, 80 and over, Clinical Trials as Topic, 10177 Dermatology Clinic, Middle Aged, Prognosis, Advanced melanoma, 3. Good health, Immunological, Oncology, 030220 oncology & carcinogenesis, 6.1 Pharmaceuticals, Toxicity, Public Health and Health Services, 2730 Oncology, Female, PD-1 inhibitors, Adult, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Oncology and Carcinogenesis, 610 Medicine & health, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Article, Antibodies, Vaccine Related, 03 medical and health sciences, Young Adult, Meta-Analysis as Topic, Internal medicine, medicine, Humans, In patient, Oncology & Carcinogenesis, Adverse effect, Pneumonitis, Aged, Immunomodulating drugs, business.industry, Evaluation of treatments and therapeutic interventions, medicine.disease, Clinical trial, 030104 developmental biology, Corticosteroid use, Immunization, business, Follow-Up Studies
وصف الملف: application/pdf; 868_Robert_C._et_al._Long-term_safety_of_pembrolizumab_monotherapy_and_relationship_with_clinical_outcome_EJC_2020.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c081e1b4e51d5ab8b097204bced3e77dTest
https://escholarship.org/uc/item/275859csTest -
3
المؤلفون: Catriona M. McNeil, Christian U. Blank, Antoni Ribas, Jean-Jacques Grob, Matteo S. Carlino, Omid Hamid, Clemens Krepler, Michal Lotem, James Larkin, Caroline Robert, Teresa M. Petrella, Paul Lorigan, Laurent Mortier, Georgina V. Long, Erin Jensen, Jacob Schachter, Scott J. Diede, Bart Neyns, Ana Arance, Adil Daud
المساهمون: Medical Oncology, Clinical sciences, Laboratory of Molecular and Medical Oncology, Laboratory of Molecullar and Cellular Therapy
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Long term survival, medicine, In patient, business, 030215 immunology, medicine.drug, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2b58ea7696aac607a6b8b94623bd747Test
https://biblio.vub.ac.be/vubir/longterm-survival-fromTest-pembrolizumab -pembro-completion-and-pembro-retreatment-phase-iii-keynote006-in-advanced-melanoma(06384d96-ea38-49d1-a40c-297993de00d7).html -
4
المؤلفون: Jonathan Cebon, Neil Steven, Mark R. Middleton, Darcy A. Hille, Erika Richtig, Céleste Lebbé, Nageatte Ibrahim, Euan Walpole, Caroline Robert, Giuseppe Masucci, Wei Zhou, Wilson H. Miller, Teresa M. Petrella
المصدر: European Journal of Cancer. 86:115-124
مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Time Factors, Longitudinal data, Health Status, Population, Ipilimumab, Pembrolizumab, Antibodies, Monoclonal, Humanized, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Quality of life, Internal medicine, medicine, Humans, In patient, Patient Reported Outcome Measures, 030212 general & internal medicine, education, Melanoma, Advanced melanoma, education.field_of_study, business.industry, Eortc qlq c30, Middle Aged, humanities, Surgery, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Quality of Life, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e890ea1bf10f65d9c5dbe680fbd78ba4Test
https://doi.org/10.1016/j.ejca.2017.08.032Test -
5
المؤلفون: Christian U. Blank, Scot Ebbinghaus, Reinhard Dummer, Carmen Loquai, Steven J. O'Day, Antoni Ribas, Adil Daud, Jacob Schachter, Caroline Robert, Janice M. Mehnert, Dirk Schadendorf, S. Peter Kang, Wei Zhou, Igor Puzanov, Darcy A. Hille, April K.S. Salama, Omid Hamid, Lee D. Cranmer, Alfons J.M. van den Eertwegh, Axel Hauschild
المساهمون: University of Zurich, Schadendorf, Dirk, Medical oncology, CCA - Clinical Therapy Development
المصدر: Schadendorf, D, Dummer, R, Hauschild, A, Robert, C, Hamid, O, Daud, A, van den Eertwegh, A, Cranmer, L, O'Day, S, Puzanov, I, Schachter, J, Blank, C, Salama, A, Loquai, C, Mehnert, J M, Hille, D, Ebbinghaus, S, Kang, S P, Zhou, W & Ribas, A 2016, ' Health-related quality of life in the randomised KEYNOTE-002 study of pembrolizumab versus chemotherapy in patients with ipilimumab-refractory melanoma ', European Journal of Cancer, vol. 67, pp. 46-54 . https://doi.org/10.1016/j.ejca.2016.07.018Test
European Journal of Cancer, 67, 46-54. Pergamonمصطلحات موضوعية: Male, Cancer Research, Skin Neoplasms, Health Status, Health-related quality of life, medicine.medical_treatment, Medizin, Pembrolizumab, Carboplatin, 0302 clinical medicine, Quality of life, Antineoplastic Combined Chemotherapy Protocols, 1306 Cancer Research, 030212 general & internal medicine, Melanoma, Aged, 80 and over, 10177 Dermatology Clinic, Middle Aged, Advanced melanoma, Dacarbazine, Oncology, 030220 oncology & carcinogenesis, Female, 2730 Oncology, medicine.drug, Adult, KEYNOTE-002, medicine.medical_specialty, Adolescent, Paclitaxel, 610 Medicine & health, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Young Adult, 03 medical and health sciences, Refractory, Internal medicine, Temozolomide, medicine, Humans, Chemotherapy, In patient, Patient Reported Outcome Measures, Aged, Patient-reported outcomes, business.industry, Cancer, EORTC QLQ-C30, medicine.disease, Surgery, Quality of Life, business, Ipilimumab-refractory melanoma
وصف الملف: 663_Schadendorf D. et al._Health-related quality of life in the randomised KEYNOTE-002_EJC 2016.pdf - application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0340a48931fc5ff52f9246c04eeed519Test
https://doi.org/10.1016/j.ejca.2016.07.018Test -
6
المؤلفون: Scott J. Diede, Reinhard Dummer, Mark M. Jones, Caroline Robert, Lev V. Demidov, James Larkin, Omid Hamid, Tae Min Kim, Georgina V. Long, Jean-Jacques Grob, Tara C. Mitchell, Janet Maleski, Ana Arance, James R. Anderson, Christian Caglevic, Stéphane Dalle, Matteo S. Carlino, Thomas F. Gajewski
المصدر: SSRN Electronic Journal.
مصطلحات موضوعية: Double blind, medicine.medical_specialty, Modified recist, Metastatic melanoma, business.industry, Internal medicine, Medicine, In patient, Epacadostat, Pembrolizumab, business, Placebo, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9e3c7630dcd1422b6cc3a19bf4a24bb7Test
https://doi.org/10.2139/ssrn.3327362Test -
7
المؤلفون: Jason Chesney, Mohammed M. Milhem, Marya F. Chaney, Wendy Snyder, Priya Gokani, Caroline Robert
المصدر: Journal of Clinical Oncology. 38:TPS10079-TPS10079
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, biology, business.industry, Melanoma, Anti pd 1, Pembrolizumab, medicine.disease, Oncolytic virus, Internal medicine, Programmed cell death 1, medicine, biology.protein, In patient, Talimogene laherparepvec, business, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::020a015b3315e6d68ddf376a2653cb85Test
https://doi.org/10.1200/jco.2020.38.15_suppl.tps10079Test -
8
المؤلفون: Christian U. Blank, James R. Anderson, Omid Hamid, Antoni Ribas, Matteo S. Carlino, Paul Lorigan, Ana Arance, Laurent Mortier, Catriona M. McNeil, Clemens Krepler, Adil Daud, Caroline Robert, Nageatte Ibrahim, Jacob Schachter, Michal Lotem, Bart Neyns, Jean-Jacques Grob, James Larkin, Teresa M. Petrella, Georgina V. Long
المصدر: Long, G V, Schachter, J, Ribas, A, Arance, A M, Grob, J-J, Mortier, L, Daud, A, Carlino, M S, McNeil, C M, Lotem, M, Larkin, J M G, Lorigan, P, Neyns, B, Blank, C U, Petrella, T M, Hamid, O, Anderson, J, Krepler, C, Ibrahim, N & Robert, C 2018, ' 4-year survival and outcomes after cessation of pembrolizumab (pembro) after 2-years in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in KEYNOTE-006. ', pp. 9503-9503 . https://doi.org/10.1200/jco.2018.36.15_suppl.9503Test
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Ipilimumab, Pembrolizumab, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, medicine, In patient, business, medicine.drug, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc84db92eee286fb74188833bd88a254Test
https://doi.org/10.1200/jco.2018.36.15_suppl.9503Test -
9
المؤلفون: Honghong Zhou, Caroline Robert, Georgina V. Long, Gil Bar-Sela, Christoph Hoeller, Christian U. Blank, Matteo S. Carlino, Dirk Schadendorf, Catherine Barrow, Antoni Ribas, Christian Caglevic, Adil Daud, Erika Richtig, Ahmed Tarhini, Erin Jensen, Pascal Wolter, Nageatte Ibrahim, Kenneth Emancipator, Marta Nyakas, Scot Ebbinghaus
مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Adolescent, Medizin, Ipilimumab, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, B7-H1 Antigen, Drug Administration Schedule, Young Adult, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Internal medicine, Humans, Medicine, In patient, Clinical significance, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, business.industry, Middle Aged, medicine.disease, Clinical trial, Treatment Outcome, 030104 developmental biology, 030220 oncology & carcinogenesis, Toxicity, Female, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::379a23f5eaed8008bb5457e825ae223bTest
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85051002457Test -
10
المؤلفون: Jeffrey E. Gershenwald, Merrick I. Ross, Nageatte Ibrahim, Charles H. Yoon, Vernon K. Sondak, Jean-Jacques Grob, Piotr Rutkowski, John M. Kirkwood, Alexander M.M. Eggermont, Andrew Poklepovic, Jason J. Luke, Richard A. Scolyer, Georgina V. Long, Sama Ahsan, Peter Mohr, James R. Anderson, Matteo S. Carlino, Caroline Robert, Axel Hauschild, Paolo A. Ascierto
المصدر: Journal of Clinical Oncology. 37:TPS9596-TPS9596
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Pembrolizumab, Placebo, 03 medical and health sciences, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Stage II melanoma, Adjuvant therapy, Medicine, In patient, Stage III melanoma, business, Adjuvant, 030215 immunology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::dfd1a33d37748bae5890bfaca892ce80Test
https://doi.org/10.1200/jco.2019.37.15_suppl.tps9596Test